Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Sperm counts largely stable after adjuvant treatment of clinical stage I testicular cancer

Key clinical point: Adjuvant treatments appear to have no significant detrimental long-term effects on sperm count in men being treated for clinical stage I testicular cancer.

Major finding: Sperm count and concentration remained stable or increased in patients treated with one cycle of chemotherapy or radiation to the lymph nodes.

Study details: A study including 182 patients 18-50 years of age with clinical stage I testicular cancer who underwent unilateral orchiectomy followed by adjuvant treatment or surveillance.

Disclosures: The study authors had no conflict of interest related to the study.


Weibring K et al. Ann Oncol. 2019 Feb 25. doi: 10.1093/annonc/mdz017/5348526.